8-K Announcements
6Apr 29, 2026·SEC
Feb 12, 2026·SEC
Jan 5, 2026·SEC
Sabra Health Care REIT, Inc. (SBRA) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the 20.8% revenue growth is encouraging, the dividend payout ratio relative to FFO has fluctuated significantly, reaching as high as 115.6% in 2023Q4, warranting further investigation into long-term distribution stability.
Sabra Health Care REIT, Inc. (SBRA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Sabra Health Care REIT, Inc. (SBRA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.39vs $0.17+134.0% | $222Mvs $209M+6.0% |
| Q1 2026 | Feb 12, 2026 | $0.38vs $0.17+123.5% | $212Mvs $198M+7.0% |
| Q4 2025 | Nov 5, 2025 | $0.38vs $0.38+0.0% | $190Mvs $202M-5.9% |
| Q3 2025 | Aug 4, 2025 | $0.38vs $0.37+2.7% | $189Mvs $187M+0.9% |
Key metrics vs top competitors for Sabra Health Care REIT, Inc. (SBRA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $19.73 | $4.98B | 30.83 | 10.15% | 20.09% | 5.59% | 6% | |
| $232.69 | $163.03B | 167.40 | 35.82% | 12.31% | 3.49% | — | |
| $92.21 | $43.84B | 170.76 | 18.47% | 4.25% | 2.08% | — | |
| $49.02 | $14.6B | 25.27 | 13.95% | 51.02% | 11.85% | — | |
| $38.77 | $1.98B | 15.38 | 25.26% | 39.08% | 10.9% | — | |
| $41.39 | $9.78B | 26.36 | 108.79% | 71.55% | 8.63% | — |
Sabra Health Care REIT, Inc. (SBRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Sabra Health Care REIT, Inc. (SBRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Feb 12, 2026·SEC
Jan 5, 2026·SEC
Get notified when SBRA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Sabra Health Care REIT, Inc. (SBRA) stock FAQ — growth, dividends, profitability & financials explained
Sabra Health Care REIT, Inc. (SBRA) reported $812.8M in revenue for fiscal year 2025. This represents a 9137% increase from $8.8M in 2010.
Sabra Health Care REIT, Inc. (SBRA) grew revenue by 10.2% over the past year. This is steady growth.
Yes, Sabra Health Care REIT, Inc. (SBRA) is profitable, generating $156.2M in net income for fiscal year 2025 (20.1% net margin).
Yes, Sabra Health Care REIT, Inc. (SBRA) pays a dividend with a yield of 6.00%. This makes it attractive for income-focused investors.
Sabra Health Care REIT, Inc. (SBRA) has a return on equity (ROE) of 5.6%. This is below average, suggesting room for improvement.
Sabra Health Care REIT, Inc. (SBRA) generated Funds From Operations (FFO) of $352.8M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Sabra Health Care REIT, Inc. (SBRA) offers a 6.00% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.